Bausch + Lomb reports mixed results; initiates FY26outlook
Source: SeekingAlpha
2026-02-18 07:01:55 ET
More on Bausch + Lomb
- Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bausch + Lomb: I Need To See Stability Before Upgrading This Name
- Bausch + Lomb completes refinancing of outstanding term B loans
- Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt
Read the full article on Seeking Alpha
For further details see:
Bausch + Lomb reports mixed results; initiates FY26outlook
Bausch + Lomb Corporation
NASDAQ: BLCO
BLCO Trading
1.85% G/L:
$17.35 Last:
60,308 Volume:
$17.10 Open:
BLCO Latest News
February 24, 2026 07:00:00 am
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
February 18, 2026 06:58:00 am
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
BLCO Stock Data
$6,074,354,796
39,385,904
0.1%
19
N/A
Medical Equipment & Supplies
Healthcare
CA
Vaughan
